Literature DB >> 20078446

Causes and place of death in Italian patients with amyotrophic lateral sclerosis.

R Spataro1, M Lo Re, T Piccoli, F Piccoli, V La Bella.   

Abstract

OBJECTIVES: To determine the causes and place of death in a cohort of Italian patients with amyotrophic lateral sclerosis (ALS). A better understanding of the likely causes of death in ALS might improve the palliative care at the end-of-life, whereas knowing the place of death will help to verify the need for highly specialized care services, e.g. hospice and nursing home. PATIENTS AND METHODS: Between 2000 and 2008, 182 ALS patients (onset: spinal, 127; bulbar, 55; M/F: 1.6) were followed in a single ALS Tertiary Centre in Palermo, Sicily, Italy until death. Medical data for each individual patient were recorded in a large database throughout the disease course. Information concerning causes and place of death were obtained by consultation with relatives or the family physician.
RESULTS: Respiratory failure (terminal respiratory insufficiency, pneumonia) was the most frequent cause of death (81.3%), which included six cases (3.3%) who requested a terminal sedation. Sudden death and death during sleep accounted for by 6.0% and 6.6% of all deaths, respectively. Heart-related causes of death were relatively infrequent in our cohort, accounting for by 7.1% of all deaths (i.e. sudden death: 6.0% and myocardial infarct: 1.1%). Patients (85.2%) died at home.
CONCLUSIONS: The leading cause of death in ALS remains the respiratory failure, followed by the sudden death and death during sleep. Most patients in our cohort died at home, a choice that might be only partially driven by cultural factors. These findings might have a great impact on the development of the advanced and end-of-life palliative care and in the planning of specialized care services, as hospice and nursing home.

Entities:  

Mesh:

Year:  2010        PMID: 20078446     DOI: 10.1111/j.1600-0404.2009.01290.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  16 in total

1.  [Causes of death in amyotrophic lateral sclerosis : Results from the Rhineland-Palatinate ALS registry].

Authors:  J Wolf; A Safer; J C Wöhrle; F Palm; W A Nix; M Maschke; A J Grau
Journal:  Nervenarzt       Date:  2017-08       Impact factor: 1.214

2.  CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.

Authors:  Daniela Rossi; Paolo Volanti; Liliana Brambilla; Tiziana Colletti; Rossella Spataro; Vincenzo La Bella
Journal:  J Neurol       Date:  2018-01-10       Impact factor: 4.849

3.  Optimizing the Translational Value of Mouse Models of ALS for Dysphagia Therapeutic Discovery.

Authors:  Kate L Osman; Sabrina Kohlberg; Alexis Mok; Ryan Brooks; Lori A Lind; Katelyn McCormack; Andries Ferreira; Matan Kadosh; Mary K Fagan; Elizabeth Bearce; Nicole L Nichols; Joan R Coates; Teresa E Lever
Journal:  Dysphagia       Date:  2019-07-12       Impact factor: 3.438

4.  Development of a prognostic model of respiratory insufficiency or death in amyotrophic lateral sclerosis.

Authors:  Jason Ackrivo; John Hansen-Flaschen; E Paul Wileyto; Richard J Schwab; Lauren Elman; Steven M Kawut
Journal:  Eur Respir J       Date:  2019-04-18       Impact factor: 16.671

5.  Determinants of accepting non-invasive ventilation treatment in motor neurone disease: a quantitative analysis at point of need.

Authors:  Rosanna Cousins; Hikari Ando; Everard Thornton; Biswajit Chakrabarti; Robert Angus; Carolyn Young
Journal:  Health Psychol Behav Med       Date:  2013-11-01

6.  An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions.

Authors:  Gary L Pattee; James P Wymer; Catherine Lomen-Hoerth; Stanley H Appel; Andrea E Formella; Laura E Pope
Journal:  Curr Med Res Opin       Date:  2014-07-28       Impact factor: 2.580

7.  Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients.

Authors:  Christian Burkhardt; Christoph Neuwirth; Andreas Sommacal; Peter M Andersen; Markus Weber
Journal:  PLoS One       Date:  2017-05-23       Impact factor: 3.240

8.  Underlying cause and place of death among patients with amyotrophic lateral sclerosis in Taiwan: a population-based study, 2003-2008.

Authors:  Ching-Piao Tsai; Bo-Hsiung Chang; Charles Tzu-Chi Lee
Journal:  J Epidemiol       Date:  2013-08-10       Impact factor: 3.211

9.  A clinical tool for predicting survival in ALS.

Authors:  Jonathan A Knibb; Noa Keren; Anna Kulka; P Nigel Leigh; Sarah Martin; Christopher E Shaw; Miho Tsuda; Ammar Al-Chalabi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-07-04       Impact factor: 10.154

10.  Cardiac Findings in Amyotrophic Lateral Sclerosis: A Magnetic Resonance Imaging Study.

Authors:  Angela Rosenbohm; Benjamin Schmid; Dominik Buckert; Wolfgang Rottbauer; Jan Kassubek; Albert C Ludolph; Peter Bernhardt
Journal:  Front Neurol       Date:  2017-09-27       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.